Published in Nucl Med Rev Cent East Eur on January 01, 2004
Impaired gastric motility and its relationship to gastrointestinal symptoms in patients with chronic renal failure. J Gastroenterol (2005) 1.00
Gastrointestinal symptoms in patients undergoing peritoneal dialysis: multivariate analysis of correlated factors. World J Gastroenterol (2010) 0.82
Peritoneal dialysis in diabetics: there is room for more. Int J Nephrol (2011) 0.80
Gastric emptying in diabetic patients by the (13)C-octanoic acid breath test: role of insulin in gastric motility. J Gastroenterol (2007) 0.79
Technetium-99m-sestamibi subtraction scintigraphy vs. ultrasonography combined with a rapid parathyroid hormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas and in directing surgical approach. Clin Endocrinol (Oxf) (2006) 2.30
Cutaneous viral infections in patients after kidney transplantation: risk factors. Pol Arch Med Wewn (2013) 2.03
Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging. Clin Endocrinol (Oxf) (2007) 1.11
Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients. Clin J Am Soc Nephrol (2011) 1.09
Tamoxifen as the possible cause of severe thromboembolic complications in a patient with a history of renal transplantation and encapsulating peritoneal sclerosis. Pol Arch Med Wewn (2013) 1.06
Dual blockade of the renin-angiotensin-aldosterone system in renal disease: what is the future? Pol Arch Med Wewn (2014) 1.05
LDL-apheresis and immunoadsorption: novel methods in the treatment of renal diseases refractory to conventional therapy. Nephrol Dial Transplant (2003) 0.92
Early detection of chronic kidney disease: results of the PolNef study. Am J Nephrol (2008) 0.92
Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis. Nephrol Dial Transplant (2004) 0.91
Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. Pol Arch Med Wewn (2013) 0.90
Trends and dynamics of changes in calcification score over the 1-year observation period in patients on peritoneal dialysis. Am J Kidney Dis (2004) 0.88
Carpal tunnel syndrome in hemodialysis patients as a dialysis-related amyloidosis manifestation--incidence, risk factors and results of surgical treatment. Med Sci Monit (2011) 0.87
Renal artery stenosis in patients with coronary artery disease. Kardiol Pol (2008) 0.87
Iodine prophylaxis--the protective factor against stomach cancer in iodine deficient areas. Eur J Nutr (2007) 0.85
[Types of hemodialysis vascular access in patients on renal replacement therapy and its complications during a one year observation period]. Przegl Lek (2011) 0.85
Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance. Metabolism (2007) 0.83
Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency. Clin Exp Nephrol (2011) 0.83
Prevalence and prediction of renal artery stenosis in patients with coronary and supraaortic artery atherosclerotic disease. Nephrol Dial Transplant (2007) 0.83
Clinical presentation of extraintestinal infections caused by non-typhoid Salmonella serotypes among patients at the University Hospital in Cracow during an 7-year period. Pol J Microbiol (2008) 0.82
Relationship between aortic pulse wave velocity, selected proinflammatory cytokines, and vascular calcification parameters in peritoneal dialysis patients. J Hypertens (2014) 0.82
[Insulin resistance indices in population-based study and their predictive value in defining metabolic syndrome]. Przegl Epidemiol (2005) 0.82
Selenium status indices, laboratory data, and selected biochemical parameters in end-stage renal disease patients. Biol Trace Elem Res (2007) 0.82
Pure red cell aplasia due to treatment with epoietin beta: first case report of PRCA from Poland. Przegl Lek (2006) 0.82
Predicting kidney function from renal biopsy. Semiquantitative versus quantitative approach. Pol J Pathol (2007) 0.81
Increased prevalence of hyperthyroidism as an early and transient side-effect of implementing iodine prophylaxis. Public Health Nutr (2007) 0.81
[A case of GH and TSH secreting pituitary macroadenoma]. Przegl Lek (2006) 0.81
[Cardiorenal syndrome--alternate challenge for nephrologist]. Przegl Lek (2011) 0.81
Identification of inflamed atherosclerotic plaque using 123 I-labeled interleukin-2 scintigraphy in high-risk peritoneal dialysis patients: a pilot study. Perit Dial Int (2009) 0.81
Relationship between serum asymmetric dimethylarginine and left ventricular structure and function in patients with end‑stage renal disease treated with hemodialysis. Pol Arch Med Wewn (2012) 0.80
[Epidemiology of kidney diseases in Poland--pilot study (PolNef)]. Przegl Lek (2004) 0.80
[Protein losing enteropathy (PLE) detected by Tc99m-labelled human serum albumin abdominal scintigraphy--case report]. Przegl Lek (2003) 0.80
Posterior retroperitoneoscopic adrenalectomy: a comparison between the initial experience in the invention phase and introductory phase of the new surgical technique. World J Surg (2007) 0.79
[The relationship between advancement of secondary hyperparathyroidism and selected calcification parameters in peritoneal dialysis patients]. Przegl Lek (2012) 0.78
[Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow]. Przegl Lek (2006) 0.78
Transforming growth factor beta 1 as a risk factor for cardiovascular diseases in end-stage renal disease patients treated with peritoneal dialysis. Clin Lab (2014) 0.78
[Prevalence of the metabolic syndrome and its components in adult inhabitants of Krakow]. Przegl Lek (2006) 0.78
Interstitial, tubular and vascular factors in progression of primary glomerulonephritis. Pol J Pathol (2007) 0.78
Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant (2004) 0.78
[Coincidence of HCV and HGV infections in hemodialysis patients]. Przegl Lek (2010) 0.78
Iodine concentration in Polish milk - variations due to season and region. Endokrynol Pol (2009) 0.78
Trends in coronary artery calcification in peritoneal dialysis and transplant patients. Nephrol Dial Transplant (2004) 0.78
Use of Tc99m-nanocolloid for sentinel nodes identification in cervical cancer. Nucl Med Rev Cent East Eur (2003) 0.78
[Hypopituitarism and hematological abnormalities mimicking myelodysplastic syndrome. Report of four cases]. Pol Arch Med Wewn (2003) 0.78
[Cardiovascular calcification and five-years mortality in patients on maintenance hemodialysis]. Przegl Lek (2011) 0.77
Dialysis adequacy, residual renal function and serum concentrations of selected low molecular weight proteins in patients undergoing continuous ambulatory peritoneal dialysis. Med Sci Monit (2003) 0.77
Peritoneal solute transport rate as an independent risk factor for total and cardiovascular mortality in a population of peritoneal dialysis patients. Adv Perit Dial (2014) 0.77
[Early diagnosis of renal diseases--preliminary results from the pilot study PolNef]. Przegl Lek (2005) 0.77
The influence of sodium profiling on blood volume and intradialytic hypotension in patients on maintenance hemodialysis. Przegl Lek (2007) 0.77
[Higher incidence of type 1 diabetes in males--a study in teenagers and young adults in Krakow region in 1987-1999]. Pol Arch Med Wewn (2006) 0.77
Hemodialysis vascular access infection and mortality in maintenance hemodialysis patients. Przegl Lek (2011) 0.77
[Environmental factors in the development of type 1 diabetes -- a new insight]. Przegl Lek (2007) 0.77
[Clinical usefulness of Nephral ST dialyzers in hemodialyzed patients with increased risk of bleeding]. Przegl Lek (2010) 0.76
[Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development]. Przegl Lek (2008) 0.76
The relationships between activation of non-specific inflammatory process and malnutrition in patients on peritoneal dialysis. Med Pregl (2007) 0.76
[Relapsing polychondritis--a challenge for modern diagnostics and treatment]. Przegl Lek (2008) 0.76
[Influence of microinflammation and oxidative stress on atherosclerosis progression and calcifications in cardiovascular system of hemodialyzed patients during two years follow-up]. Przegl Lek (2007) 0.76
Serum uromodulin concentrations correlate with glomerular filtration rate in patients with chronic kidney disease. Pol Arch Med Wewn (2016) 0.76
[Assessment of early immunosuppressive therapy in the prevention of complications of Graves' disease]. Przegl Lek (2004) 0.75
Vitamin K in chronic kidney disease: time for a (hint of) hope? Pol Arch Med Wewn (2015) 0.75
High rate of aspirin resistance in advanced kidney failure: does it matter? Kardiol Pol (2014) 0.75
Comment on "Cutaneous viral infections in patients after kidney transplantation: risk factors". Authors' reply. Pol Arch Med Wewn (2014) 0.75
Association between gastric emptying rate and nutritional status in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int (2002) 0.75
[Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age]. Pol Merkur Lekarski (2014) 0.75
Pulse wave velocity and proteins regulating vascular calcification and bone mineralization in patients treated with peritoneal dialysis. Nephrol Dial Transplant (2006) 0.75
In search for a biochemical marker of overhydration in hemodialysis: the "magic bullet" yet to be found. Pol Arch Med Wewn (2015) 0.75
[The new measurement technics in biology and medicine--atomic force microscopy]. Przegl Lek (2003) 0.75
[Present opinions concerning the administration of low molecular weight heparins in hemodialysis patients]. Przegl Lek (2005) 0.75
Coexistence of 2 malignant urogenital neoplasms: a testicular seminoma and adenocarcinoma of the prostate gland in a patient 1 year after kidney transplantation. Pol Arch Med Wewn (2016) 0.75
[Factors predisposing to malnutrition development in the patients on maintenance hemodialysis]. Przegl Lek (2005) 0.75
[Fibroblast growth factor-23 (FGF-23). Part II. Significance in chronic kidney disease]. Przegl Lek (2011) 0.75
[Percutaneous renal denervation as a new method of treatment of resistant arterial hypertension]. Przegl Lek (2012) 0.75
The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization. Przegl Lek (2007) 0.75
[Post transplant lymphoprolipherative disorder (PTLD) in patients after kidney transplantation--clinical manifestation, treatment and prognosis]. Przegl Lek (2012) 0.75
[Influence of elevated homocystein level and selected lipid parameters in kidney transplant patients on the progression of atherosclerotic changes assessed by intima-media thickness index (CCA-IMT)]. Przegl Lek (2012) 0.75
Abernethy malformation type I (congenital absence of the portal vein) in a patient with chronic kidney disease. Pol Arch Med Wewn (2016) 0.75
[The role of kidney in pathogenesis of arterial hypertension]. Przegl Lek (2012) 0.75
Pentraxin3 as a new indicator of cardiovascular-related death in patients with advanced chronic kidney disease? Pol Arch Intern Med (2017) 0.75
[Post transplant lymphoproliferative disorder (PTLD)--10 years follow-up]. Przegl Lek (2011) 0.75
[Pilot study of aluminum plasma level in healthy subjects in Poland]. Przegl Lek (2003) 0.75
[Disadvantages and benefits of early initiation of dialysotherapy]. Przegl Lek (2011) 0.75
[Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis]. Przegl Lek (2007) 0.75
[Fibroblast growth factor-23 (FGF-23). Part I. Significance in phosphate homeostasis and bone metabolism]. Przegl Lek (2011) 0.75
[Fibroblast growth factor-23 (FGF-23). Part III. Relationship between FGF-23 serum concentration and cardio-vascular morbidity and mortality]. Przegl Lek (2011) 0.75
[Nonfunctional pituitary adenoma and pulmonary sarcoidosis--a case report]. Przegl Lek (2002) 0.75
[Postprandial hypotension and gastric emptying in longstanding diabetes mellitus]. Przegl Lek (2003) 0.75
[New measurement techniques in biology and medicine: atomic force microscopy (part III)]. Przegl Lek (2004) 0.75
Clinical and scintigraphic (99mTc-MIBI SPECT) heart evaluation in young acutely carbon monoxide poisoned patients. Przegl Lek (2003) 0.75
[Pituitary tumors: hormonal status and immunohistochemical evaluation]. Przegl Lek (2003) 0.75
Pentraxin 3 as a new indicator of cardiovascular‑related death in patients with advanced chronic kidney disease. Pol Arch Intern Med (2017) 0.75
[New immune suppressants: topical immunomodulatory agents]. Przegl Lek (2002) 0.75